Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
PainChek Ltd ( (AU:PCK) ) just unveiled an announcement.
PainChek Ltd announced an upcoming investor webinar to discuss their quarterly update and financial performance. The company, which has contracts with over 1,900 aged care facilities and has conducted more than 12 million digital pain assessments, is expanding its reach into home care markets. This move is expected to enhance its market positioning and provide further opportunities for growth, particularly in supporting pain management for individuals living at home.
More about PainChek Ltd
PainChek Ltd is a company operating in the medical device industry, known for developing the world’s first smart device-based pain assessment and monitoring application. Their primary product, the PainChek app, is designed to facilitate best-practice pain management for individuals who cannot reliably self-report their pain. The app is available on smartphones and tablets and combines AI-driven pain assessment with the Numerical Rating Scale, allowing for accurate and consistent pain evaluation. PainChek has achieved regulatory clearance in multiple countries, including Australia, Canada, and the European Union, and is expanding into home care by partnering with home care and disability service providers.
Average Trading Volume: 1,773,204
Technical Sentiment Signal: Buy
Current Market Cap: A$73.68M
See more insights into PCK stock on TipRanks’ Stock Analysis page.